August 27, 2015 — The use of computational fluid dynamics (CFD) modeling has been used for years to better engineer large machines such as aircraft and automobiles, but its application is now being turned toward implantable medical devices such as stents, stent grafts and heart valves. Last November, the U.S. Food and Drug Administration (FDA) approved the first medical technology that uses CFD to create noninvasive fraction flow reserve (FFR) measurements of blood flow through coronary lesions based on a computed tomography (CT) scan.
